Stem cell transplantation for polycythemia vera

Pediatric Blood and Cancer

Volumn 50, Issue 1, 2008, Pages 124-126

  Reinhard, Harald ^a   Klingebiel, Thomas ^b   Lang, Peter ^c   Bader, Peter ^b   Niethammer, Dietrich ^c   Graf, Norbert ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Chimerism; Polycythemia vera; Stem cell transplantation

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CYCLOPHOSPHAMIDE; THYMOCYTE ANTIBODY;

ANAMNESIS; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CHIMERA; CLINICAL FEATURE; FOLLOW UP; HEPATOMEGALY; HUMAN; LABORATORY TEST; MALE; OUTCOME ASSESSMENT; PHLEBOTOMY; PHYSICAL EXAMINATION; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; STEM CELL TRANSPLANTATION; T CELL DEPLETION; T LYMPHOCYTE; TREATMENT OUTCOME;

CHILD; HUMANS; MALE; POLYCYTHEMIA VERA; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 36849045667     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20906     Document Type: Article

References (15)

1. Spivak JL. Polycytemia vera: Myths, mechanisms and management. Blood 2002;100:4272-4290.
2. Pasamonti F, Malabarba L, Orlandi E, et al. Polycythemia vera in young patients: A study on the long-term risk of thrombosis, myelofibrosis and leukemia. Haematologica 2003;88:13-18.
3. Lang P, Klingebiel T, Bader P, et al. Transplantation of highly purified peripheral blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases. Bone Marrow Transplant 2003;00:1-8.
4. Bader P, Holle W, Klingebiel T. Quantitative assessment of mixed hematopoietic chimerism by polymerase chain reaction after allogenic BMT. Anticancer Res 1996;16:1759-1763.
5. Osgood EE. Polycythemia vera: Age relationship and survival. Blood 1965;26:243-256.
6. Spivak JL. The optimal management of polycythaemia vera. Br J Haematol 2002;116:243-254.
7. Gilbert HS. Current management of polycythemia vera. Semin Hematol 2001;38:25-28.
8. Lengfelder E, Berger U, Hehlmann R. Interferon α in the treatment of polycythemia vera. Ann Hematol 2000;79:103-109.
9. Pescatore SL, Lindley C. Anagrelide: A novel agent for the treatment of myeloproliferative disorders. Expert Opin Pharmacother 2000;1:537-546.
10. Turker M, Ozer EA, Oniz H, et al. Polycythemia vera in a 12-year-old girl: A case report. Pediatr Hematol Oncol 2002;19:263-266.
11. Perea G, Remacha A, Besses C, et al. Is polycythemia vera a serious disease in young patients ? Haematologica 2001;86:543-544.
12. Stobart K, Rogers PCJ. Allogenic bone marrow transplantation for an adolescent with polycythemia vera. Bone Marrow Transplant 1994;13:337-339.
13. Anderson JE, Sale G, Appelbaum FR, et al. Allogenic marrow transplantaion for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis. Br J Haematol 1997;98:1010-1016
14. Jurado M, Deeg HJ, Gooley T. Haematopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia. Br J Haematol 2001;112:392-396.
15. Przepiorka D, Giralt S, Khouri I, et al. Allogenic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: Review of forty cases. Am J Hematol 1998;57:24-28.